Evidence map›Paper›PMID 31993834›Full record

ReviewCurrent cardiology reports2020

Microvascular Angina Diagnosed by Absolute PET Myocardial Blood Flow Quantification.

Matthieu Pelletier-Galarneau, Vasken Dilsizian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2025
    Article
  3. Article
  4. Article
  5. Non-invasive diagnosis of vasospastic angina.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. On the relationship between coronary microvascular disease and obesity.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  10. Review
  11. Review
  12. The New Role of Cardiac Imaging Following the ISCHEMIA Trial.Current treatment options in cardiovascular medicine · 2021
    Article
  13. Comparison of myocardial blood flow and flow reserve with dobutamine and dipyridamole stress using rubidium-82 positron emission tomography.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Matthieu Pelletier-GalarneauDepartment of Medical Imaging, Institut de cardiologie de Montréal, Université de Montréal, Montréal, Québec, Canada. matthieu.pelletier-galarneau@icm-mhi.org.
Vasken DilsizianDepartment of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Université de Montréal · CAUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe aim of this review is to provide an update on the use of positron emission tomography (PET) with myocardial blood flow (MBF) quantification for the diagnosis and management of patients with microvascular disease. RECENT

findingsIt is now recognized that a large proportion of patients with classical angina and non-obstructive epicardial disease are suffering from microvascular angina. Microvascular angina shares several key features with epicardial coronary disease, including many risk factors. Clinical criteria for the diagnosis of microvascular angina were recently proposed and PET imaging is called to play a central role in evaluation of these patients. Indeed, PET allows non-invasive measurements of MBF and flow reserve, which are altered in microvascular dysfunction. Furthermore, PET with flow quantification provides independent prognostic information and has the potential to monitor response to therapy in microvascular disease. PET with MBF quantification allows detection of microvascular dysfunction and plays a key role in the investigation of patients with suspected microvascular angina.

Indexed as

Coronary AngiographyCoronary Artery DiseaseCoronary CirculationFractional Flow Reserve, MyocardialHumansMicrocirculationMicrovascular AnginaMyocardial Perfusion ImagingPositron-Emission TomographyEndothelial dysfunctionMicrovascular anginaMicrovascular dysfunctionMyocardial blood flowMyocardial flow reservePositron emission tomography

Identifiers

PMID31993834
OpenAlexW3003769574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.